3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
8
Neoplasm Metastasis
6
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Stomach Neoplasms
2
Prostatic Neoplasms
2
Endometrial Neoplasms
2
Advanced Breast Cancer
2
Adenocarcinoma
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Salivary Gland Neoplasms
1
Neoplasms
1
Mouth Neoplasms
1
Melanoma
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
HER2-Positive Primary Breast Cancer
1
Glioma
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Interventions
Specimen Handling
3
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Biopsy
2
olaparib
1
durvalumab
1
cediranib
1
capivasertib
1
cabozantinib
1
Ipilimumab
1
Immunoglobulin G
1
Fluid Therapy
1
Disulfides
1
CTLA-4 Antigen
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinosarcoma
×
trastuzumab deruxtecan
×
30 days
×
Clear all
No trials found.